Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study

BACKGROUND: Piperacillin/tazobactam (PIPC/TAZ) and cefepime (CFPM) are commonly used for the treatment of nosocomial and healthcare-associated infections. Recent reports have suggested that the incidence of acute kidney injury (AKI) in patients treated with a combination of vancomycin (VCM) and PIPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadomura, Shota, Takekuma, Yoh, Sato, Yuki, Sumi, Masato, Kawamoto, Kotaro, Itoh, Tatsuya, Sugawara, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560868/
https://www.ncbi.nlm.nih.gov/pubmed/31210955
http://dx.doi.org/10.1186/s40780-019-0142-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560868/
https://www.ncbi.nlm.nih.gov/pubmed/31210955
http://dx.doi.org/10.1186/s40780-019-0142-6

Ejemplares similares